+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Enhanced growth and sodium-proton antiport activity response to serum in cultured fibroblasts of diabetic patients with nephropathy



Enhanced growth and sodium-proton antiport activity response to serum in cultured fibroblasts of diabetic patients with nephropathy



Acta Diabetologica 29(3-4): 178-181




(PDF emailed within 1 workday: $29.90)

Accession: 031250103

Download citation: RISBibTeXText


Related references

Overactivity of sodium proton antiport and enhanced cell growth in fibroblasts of type 1 insulin dependent diabetic patients with nephropathy. Diabetologia 32(7): 549A, 1989

Overactivity of sodium proton antiport and enhanced cell growth in fibroblasts of type 1 insulin dependent diabetics with nephropathy. Kidney International 37(1): 199, 1990

Platelet sodium proton antiport activity in patients with insulin dependent diabetes mellitus with and without diabetic nephropathy. Journal of the American Society of Nephrology 2(3): 288, 1991

Na+/H+ antiport activity and cell growth in cultured skin fibroblasts of IDDM patients with nephropathy. Diabetes 41(10): 1239-1246, 1992

Enhanced proliferation in cultured skin fibroblasts from patients with type I diabetes and nephropathy Role of sodium-proton antiporter. Journal Of The American Society Of Nephrology. 3(3): 761, 1992

Proliferation and Na+/H+ antiport activity in human fibroblasts from type I diabetic patients with nephropathy. American Journal of Hypertension 6(2): 170-173, 1993

Aberrant behaviour of cultured skin fibroblasts from type 1 diabetic patients with nephropathy in response to serum induced cell cycle entry. Journal of the American Society of Nephrology 10(PROGRAM AND ABSTR ISSUE): 489A, Sept, 1999

Enhanced collagen synthesis in cultured skin fibroblasts from insulin-dependent diabetic patients with nephropathy. Journal of the American Society of Nephrology 8(7): 1133-1139, 1997

Sodium proton antiport activity in skin fibroblasts from blacks and whites. Hypertension 15(2): 140-145, 1990

Leukocyte ph and sodium proton antiport activity in type 1 insulin dependent diabetes with nephropathy. Diabetologia 32(7): 522A, 1989

Erythrocyte sodium-hydrogen antiport activity is not a predictor of diabetic nephropathy. Hormone and Metabolic Research 28(8): 388-393, 1996

Cyclin dependent kinase inhibitor p16 is decreased in cultured skin fibroblasts from type 1 diabetic patients with nephropathy A marker of diabetic nephropathy ?. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 638A, 2000

Cyclin dependent kinase inhibitor p16 is decreased in cultured skin fibroblasts from type 1 diabetic patients with nephropathy An early marker of diabetic nephropathy. Journal of Investigative Medicine 48(5): 265A, 2000

Simvastatin affects ph regulation of sv40 transformed mrc5 fibroblasts by inhibition of sodium proton antiport activity. British Journal of Pharmacology 105(PROC SUPPL APRIL): 203P, 1992

In situ protein kinase C activity in cultured fibroblasts from type 1 diabetic patients with nephropathy. Diabetologia 41(SUPPL 1): A75, 1998